Literature DB >> 23571156

A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties.

Thomas Tiller1, Ingrid Schuster1, Dorothée Deppe1, Katja Siegers1, Ralf Strohner1, Tanja Herrmann1, Marion Berenguer1, Dominique Poujol1, Jennifer Stehle1, Yvonne Stark1, Martin Heßling1, Daniela Daubert1, Karin Felderer1, Stefan Kaden1, Johanna Kölln1, Markus Enzelberger1, Stefanie Urlinger1.   

Abstract

This report describes the design, generation and testing of Ylanthia, a fully synthetic human Fab antibody library with 1.3E+11 clones. Ylanthia comprises 36 fixed immunoglobulin (Ig) variable heavy (VH)/variable light (VL) chain pairs, which cover a broad range of canonical complementarity-determining region (CDR) structures. The variable Ig heavy and Ig light (VH/VL) chain pairs were selected for biophysical characteristics favorable to manufacturing and development. The selection process included multiple parameters, e.g., assessment of protein expression yield, thermal stability and aggregation propensity in fragment antigen binding (Fab) and IgG1 formats, and relative Fab display rate on phage. The framework regions are fixed and the diversified CDRs were designed based on a systematic analysis of a large set of rearranged human antibody sequences. Care was taken to minimize the occurrence of potential posttranslational modification sites within the CDRs. Phage selection was performed against various antigens and unique antibodies with excellent biophysical properties were isolated. Our results confirm that quality can be built into an antibody library by prudent selection of unmodified, fully human VH/VL pairs as scaffolds.

Entities:  

Keywords:  CDR-H3 design; Slonomics; VH/VL pairing; Ylanthia; antibody engineering; human antibody library; phage display

Mesh:

Substances:

Year:  2013        PMID: 23571156      PMCID: PMC4169037          DOI: 10.4161/mabs.24218

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  76 in total

1.  Structural repertoire of the human VH segments.

Authors:  C Chothia; A M Lesk; E Gherardi; I M Tomlinson; G Walter; J D Marks; M B Llewelyn; G Winter
Journal:  J Mol Biol       Date:  1992-10-05       Impact factor: 5.469

2.  Coevolution of antibody stability and Vκ CDR-L3 canonical structure.

Authors:  Jinquan Luo; Galina Obmolova; Alice Huang; Brandy Strake; Alexey Teplyakov; Thomas Malia; Salman Muzammil; Yonghong Zhao; Gary L Gilliland; Yiqing Feng
Journal:  J Mol Biol       Date:  2010-08-18       Impact factor: 5.469

3.  The GeneOptimizer Algorithm: using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization.

Authors:  David Raab; Marcus Graf; Frank Notka; Thomas Schödl; Ralf Wagner
Journal:  Syst Synth Biol       Date:  2010-09-01

4.  Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis.

Authors:  B Virnekäs; L Ge; A Plückthun; K C Schneider; G Wellnhofer; S E Moroney
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

5.  Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions.

Authors:  D Dunn-Walters; L Boursier; J Spencer
Journal:  Mol Immunol       Date:  2000 Feb-Mar       Impact factor: 4.407

6.  Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3.

Authors:  Robert Rauchenberger; Eric Borges; Elisabeth Thomassen-Wolf; Eran Rom; Rivka Adar; Yael Yaniv; Michael Malka; Irina Chumakov; Sarit Kotzer; Dalia Resnitzky; Achim Knappik; Silke Reiffert; Josef Prassler; Karin Jury; Dirk Waldherr; Susanne Bauer; Titus Kretzschmar; Avner Yayon; Christine Rothe
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

7.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

Authors:  Michael Zemlin; Martin Klinger; Jason Link; Cosima Zemlin; Karl Bauer; Jeffrey A Engler; Harry W Schroeder; Perry M Kirkham
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

8.  Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity.

Authors:  L Olsson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

9.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

10.  A checkpoint for autoreactivity in human IgM+ memory B cell development.

Authors:  Makoto Tsuiji; Sergey Yurasov; Klara Velinzon; Saskia Thomas; Michel C Nussenzweig; Hedda Wardemann
Journal:  J Exp Med       Date:  2006-01-30       Impact factor: 14.307

View more
  72 in total

1.  Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Authors:  Andreas Lehmann; Josephine H F Wixted; Maxim V Shapovalov; Heinrich Roder; Roland L Dunbrack; Matthew K Robinson
Journal:  MAbs       Date:  2015-09-04       Impact factor: 5.857

2.  Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.

Authors:  Wolfgang Schaefer; Hans R Völger; Stefan Lorenz; Sabine Imhof-Jung; Jörg T Regula; Christian Klein; Michael Mølhøj
Journal:  MAbs       Date:  2015-10-23       Impact factor: 5.857

3.  Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.

Authors:  Sue Townsend; Brian J Fennell; James R Apgar; Matthew Lambert; Barry McDonnell; Joanne Grant; Jason Wade; Edward Franklin; Niall Foy; Deirdre Ní Shúilleabháin; Conor Fields; Alfredo Darmanin-Sheehan; Amy King; Janet E Paulsen; Timothy P Hickling; Lioudmila Tchistiakova; Orla Cunningham; William J J Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

4.  Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

Authors:  Ryan L Kelly; Doris Le; Jessie Zhao; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-11-26       Impact factor: 5.469

5.  Boosting antibody developability through rational sequence optimization.

Authors:  Daniel Seeliger; Patrick Schulz; Tobias Litzenburger; Julia Spitz; Stefan Hoerer; Michaela Blech; Barbara Enenkel; Joey M Studts; Patrick Garidel; Anne R Karow
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.

Authors:  Melissa L Geddie; Neeraj Kohli; Dmitri B Kirpotin; Maja Razlog; Yang Jiao; Tad Kornaga; Rachel Rennard; Lihui Xu; Birgit Schoerberl; James D Marks; Daryl C Drummond; Alexey A Lugovskoy
Journal:  MAbs       Date:  2016-11-17       Impact factor: 5.857

7.  Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.

Authors:  Anna Z Wec; Andrew S Herbert; Charles D Murin; Elisabeth K Nyakatura; Dafna M Abelson; J Maximilian Fels; Shihua He; Rebekah M James; Marc-Antoine de La Vega; Wenjun Zhu; Russell R Bakken; Eileen Goodwin; Hannah L Turner; Rohit K Jangra; Larry Zeitlin; Xiangguo Qiu; Jonathan R Lai; Laura M Walker; Andrew B Ward; John M Dye; Kartik Chandran; Zachary A Bornholdt
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

8.  A Combination of Structural and Empirical Analyses Delineates the Key Contacts Mediating Stability and Affinity Increases in an Optimized Biotherapeutic Single-chain Fv (scFv).

Authors:  Chao Tu; Virginie Terraube; Amy Sze Pui Tam; Wayne Stochaj; Brian J Fennell; Laura Lin; Mark Stahl; Edward R LaVallie; Will Somers; William J J Finlay; Lydia Mosyak; Joel Bard; Orla Cunningham
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

9.  Characterization and screening of IgG binding to the neonatal Fc receptor.

Authors:  Tobias Neuber; Katrin Frese; Jan Jaehrling; Sebastian Jäger; Daniela Daubert; Karin Felderer; Mechthild Linnemann; Anne Höhne; Stefan Kaden; Johanna Kölln; Thomas Tiller; Bodo Brocks; Ralf Ostendorp; Stefan Pabst
Journal:  MAbs       Date:  2014-04-07       Impact factor: 5.857

Review 10.  Combinatorial antibody libraries: new advances, new immunological insights.

Authors:  Richard A Lerner
Journal:  Nat Rev Immunol       Date:  2016-07-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.